Literature DB >> 22121306

TIEG1-NULL OSTEOCYTES DISPLAY DEFECTS IN THEIR MORPHOLOGY, DENSITY AND SURROUNDING BONE MATRIX.

Oualid Haddad1, John R Hawse, Malayannan Subramaniam, Thomas C Spelsberg, Sabine F Bensamoun.   

Abstract

Through the development of TGFβ-inducible early gene-1 (TIEG1) knockout (KO) mice, we have demonstrated that TIEG1 plays an important role in osteoblast-mediated bone mineralization, and in bone resistance to mechanical strain. To further investigate the influence of TIEG1 in skeletal maintenance, osteocytes were analyzed by transmission electron microscopy using TIEG1 KO and wild-type mouse femurs at one, three and eight months of age. The results revealed an age-dependent change in osteocyte surface and density, suggesting a role for TIEG1 in osteocyte development. Moreover, there was a decrease in the amount of hypomineralized bone matrix surrounding the osteocytes in TIEG1 KO mice relative to wild-type controls. While little is known about the function or importance of this hypomineralized bone matrix immediately adjacent to osteocytes, this study reveals significant differences in this bone microenvironment and suggests that osteocyte function may be compromised in the absence of TIEG1 expression.

Entities:  

Year:  2009        PMID: 22121306      PMCID: PMC3222944          DOI: 10.1142/S0218957709002304

Source DB:  PubMed          Journal:  J Musculoskelet Res        ISSN: 0218-9577


  37 in total

1.  Mechanosensation and Transduction in Osteocytes.

Authors:  Lynda F Bonewald
Journal:  Bonekey Osteovision       Date:  2006-10

2.  A case for bone canaliculi as the anatomical site of strain generated potentials.

Authors:  S C Cowin; S Weinbaum; Y Zeng
Journal:  J Biomech       Date:  1995-11       Impact factor: 2.712

3.  Sensitivity of osteocytes to biomechanical stress in vitro.

Authors:  J Klein-Nulend; A van der Plas; C M Semeins; N E Ajubi; J A Frangos; P J Nijweide; E H Burger
Journal:  FASEB J       Date:  1995-03       Impact factor: 5.191

4.  A model for the excitation of osteocytes by mechanical loading-induced bone fluid shear stresses.

Authors:  S Weinbaum; S C Cowin; Y Zeng
Journal:  J Biomech       Date:  1994-03       Impact factor: 2.712

5.  Decline in osteocyte lacunar density in human cortical bone is associated with accumulation of microcracks with age.

Authors:  D Vashishth; O Verborgt; G Divine; M B Schaffler; D P Fyhrie
Journal:  Bone       Date:  2000-04       Impact factor: 4.398

6.  Tissue, cell type, and breast cancer stage-specific expression of a TGF-beta inducible early transcription factor gene.

Authors:  M Subramaniam; T E Hefferan; K Tau; D Peus; M Pittelkow; S Jalal; B L Riggs; P Roche; T C Spelsberg
Journal:  J Cell Biochem       Date:  1998-02-01       Impact factor: 4.429

7.  Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein.

Authors:  M E Brunkow; J C Gardner; J Van Ness; B W Paeper; B R Kovacevich; S Proll; J E Skonier; L Zhao; P J Sabo; Y Fu; R S Alisch; L Gillett; T Colbert; P Tacconi; D Galas; H Hamersma; P Beighton; J Mulligan
Journal:  Am J Hum Genet       Date:  2001-02-09       Impact factor: 11.025

8.  Decreased bone mass and bone elasticity in mice lacking the transforming growth factor-beta1 gene.

Authors:  A G Geiser; Q Q Zeng; M Sato; L M Helvering; T Hirano; C H Turner
Journal:  Bone       Date:  1998-08       Impact factor: 4.398

9.  Ultrastructure of the osteocyte process and its pericellular matrix.

Authors:  Li-Dan You; Sheldon Weinbaum; Stephen C Cowin; Mitchell B Schaffler
Journal:  Anat Rec A Discov Mol Cell Evol Biol       Date:  2004-06

10.  Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist.

Authors:  Rutger L van Bezooijen; Bernard A J Roelen; Annemieke Visser; Lianne van der Wee-Pals; Edwin de Wilt; Marcel Karperien; Herman Hamersma; Socrates E Papapoulos; Peter ten Dijke; Clemens W G M Löwik
Journal:  J Exp Med       Date:  2004-03-15       Impact factor: 14.307

View more
  7 in total

1.  Serum and Soleus Metabolomics Signature of Klf10 Knockout Mice to Identify Potential Biomarkers.

Authors:  Nadine Baroukh; Nathan Canteleux; Antoine Lefèvre; Camille Dupuy; Cécile Martias; Antoine Presset; Malayannan Subramaniam; John R Hawse; Patrick Emond; Philippe Pouletaut; Sandrine Morandat; Sabine F Bensamoun; Lydie Nadal-Desbarats
Journal:  Metabolites       Date:  2022-06-17

Review 2.  Functional role of KLF10 in multiple disease processes.

Authors:  Malayannan Subramaniam; John R Hawse; Nalini M Rajamannan; James N Ingle; Thomas C Spelsberg
Journal:  Biofactors       Date:  2010 Jan-Feb       Impact factor: 6.113

3.  TGFβ inducible early gene-1 plays an important role in mediating estrogen signaling in the skeleton.

Authors:  John R Hawse; Kevin S Pitel; Muzaffer Cicek; Kenneth A Philbrick; Anne Gingery; Kenneth D Peters; Farhan A Syed; James N Ingle; Vera J Suman; Urszula T Iwaniec; Russell T Turner; Thomas C Spelsberg; Malayannan Subramaniam
Journal:  J Bone Miner Res       Date:  2014       Impact factor: 6.741

4.  TIEG1/KLF10 modulates Runx2 expression and activity in osteoblasts.

Authors:  John R Hawse; Muzaffer Cicek; Sarah B Grygo; Elizabeth S Bruinsma; Nalini M Rajamannan; Andre J van Wijnen; Jane B Lian; Gary S Stein; Merry Jo Oursler; Malayannan Subramaniam; Thomas C Spelsberg
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

5.  Impact of TIEG1 Deletion on the Passive Mechanical Properties of Fast and Slow Twitch Skeletal Muscles in Female Mice.

Authors:  Malek Kammoun; Philippe Pouletaut; Francis Canon; Malayannan Subramaniam; John R Hawse; Muriel Vayssade; Sabine F Bensamoun
Journal:  PLoS One       Date:  2016-10-13       Impact factor: 3.240

Review 6.  KLF10 as a Tumor Suppressor Gene and Its TGF-β Signaling.

Authors:  Azra Memon; Woon Kyu Lee
Journal:  Cancers (Basel)       Date:  2018-05-25       Impact factor: 6.639

7.  A KDM6A-KLF10 reinforcing feedback mechanism aggravates diabetic podocyte dysfunction.

Authors:  Chun-Liang Lin; Yung-Chien Hsu; Yu-Ting Huang; Ya-Hsueh Shih; Ching-Jen Wang; Wen-Chih Chiang; Pey-Jium Chang
Journal:  EMBO Mol Med       Date:  2019-05       Impact factor: 12.137

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.